Brief: Control Bionics Posts YTD Unaudited Rev To 31 May 2025 A$5.4M
13/06/2025 01:30
June 13 (Reuters) - Control Bionics Ltd CBL.AX: YTD UNAUDITED REVENUE TO 31 MAY 2025 A$5.4M Further company coverage: CBL.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Control Bionics
See all newsBrief: Control Bionics Posts Full-Year Loss Attributable Of A$7.3 Million
Brief: Control Bionics Sees FY27 Revenue Growth Of 50% Over FY26
Brief: Control Bionics Says Medicare Billing Code Secured For Nextlevel Speech Devices
Brief: Control Bionics Receives UK MHRA Registration For Neurostrip
Australia's Control Bionics jumps after FDA listing for NeuroStrip device